Bruklyn Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-01-2025
- Paid Up Capital ₹ 0.55 M
as on 03-01-2025
- Company Age 24 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.82 M
as on 03-01-2025
- Revenue 23.56%
(FY 2019)
- Profit -121.47%
(FY 2019)
- Ebitda -1976.84%
(FY 2019)
- Net Worth -7.26%
(FY 2019)
- Total Assets -6.46%
(FY 2019)
About Bruklyn Pharma Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.55 M.
The company currently has active open charges totaling ₹7.82 M.
Jayalakshmi Nandakumar, Cheruparambathu Nandakumar, Jithendran Achuthan, and One other member serve as directors at the Company.
- CIN/LLPIN
U51109KL2000PTC014340
- Company No.
014340
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bruklyn Pharma Distributors?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Cheruparambathu Nandakumar  | Managing Director | 23-Nov-2000 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jithendran Achuthan | Director | 23-Nov-2000 | Current |
| Jayalakshmi Nandakumar | Director | 23-Nov-2000 | Current |
| Jayashree Jithendran | Director | 23-Nov-2000 | Current |
Financial Performance of Bruklyn Pharma Distributors.
Bruklyn Pharma Distributors Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 23.56% increase. The company also saw a substantial fall in profitability, with a 121.47% decrease in profit. The company's net worth dipped by a decrease of 7.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bruklyn Pharma Distributors?
In 2019, Bruklyn Pharma Distributors had a promoter holding of 81.82% and a public holding of 18.18%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Gratefix Fastening Solutions Private LimitedActive 13 years 6 months
Jithendran Achuthan and Jayashree Jithendran are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Oct 2009 | ₹0.27 M | Open |
The Federal Bank Limited Creation Date: 07 Mar 2008 | ₹3.50 M | Open |
Mohanan C. Creation Date: 12 Aug 2004 | ₹3.00 M | Open |
How Many Employees Work at Bruklyn Pharma Distributors?
Unlock and access historical data on people associated with Bruklyn Pharma Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bruklyn Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bruklyn Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
